Observational studyPloS one2017

Is the risk of progressive multifocal leukoencephalopathy the real reason for natalizumab discontinuation in patients with multiple sclerosis?

Julia Krämer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.